v3.24.3
Cover Page - shares
9 Months Ended
Sep. 30, 2024
Oct. 28, 2024
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2024  
Document Transition Report false  
Entity File Number 001-36274  
Entity Registrant Name INTRA-CELLULAR THERAPIES, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 36-4742850  
Entity Address, Address Line One 135 Route 202/206, Suite 6  
Entity Address, City or Town Bedminster  
Entity Address, State or Province NJ  
Entity Address, Postal Zip Code 07921  
City Area Code 646  
Local Phone Number 440-9333  
Title of 12(b) Security Common Stock  
Trading Symbol ITCI  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   106,017,103
Entity Central Index Key 0001567514  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Amendment Flag false